Immunocore (IMCR) Stock Forecast, Price Target & Predictions
IMCR Stock Forecast
Immunocore stock forecast is as follows: an average price target of $70.75 (represents a 120.27% upside from IMCR’s last price of $32.12) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
IMCR Price Target
IMCR Analyst Ratings
Buy
Immunocore Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 24, 2024 | David Dai | UBS | - | - | -25.05% | -25.28% |
Sep 16, 2024 | Justin Kim | Oppenheimer | - | - | 169.29% | 177.09% |
Sep 12, 2024 | Graig Suvannavejh | Mizuho Securities | - | - | 115.31% | 124.16% |
Aug 28, 2024 | Patrick Trucchio | H.C. Wainwright | - | - | 180.03% | 211.33% |
Aug 09, 2024 | Peter Lawson | Barclays | - | - | 74.05% | 105.48% |
May 13, 2024 | Graig Suvannavejh | Mizuho Securities | - | - | 53.71% | 173.97% |
May 09, 2024 | Bill Maughan | Canaccord Genuity | - | - | 9.26% | 108.59% |
Dec 15, 2022 | Rajan Sharma | Goldman Sachs | - | - | 34.63% | 149.07% |
Sep 09, 2022 | Michael Yee | Jefferies | - | - | 54.43% | 111.71% |
10
Immunocore Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 4 | 7 |
Avg Price Target | $24.00 | $71.25 | $72.29 |
Last Closing Price | $32.12 | $32.12 | $32.12 |
Upside/Downside | -25.28% | 121.82% | 125.06% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 24, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Oct 24, 2024 | UBS | Buy | Buy | Hold |
Oct 24, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Oct 24, 2024 | UBS | Sell | Initialise | |
Oct 07, 2024 | Needham | Underperform | Underperform | Hold |
Oct 07, 2024 | Oppenheimer | Buy | Buy | Hold |
Oct 07, 2024 | Guggenheim | Neutral | Downgrade | |
Sep 16, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Sep 16, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 28, 2024 | Oppenheimer | Buy | Buy | Hold |
10
Immunocore Financial Forecast
Immunocore Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $105.64M | $51.49M | - | $44.54M | $48.06M | $41.20M | $32.00M | $22.47M | $6.59M | $5.92M | $5.73M | $8.27M | $7.42M |
Avg Forecast | $91.86M | $93.20M | $92.95M | $92.44M | $92.14M | $90.42M | $88.25M | $86.04M | $84.53M | $78.94M | $74.58M | $69.47M | $66.58M | $62.79M | $57.76M | $49.51M | $52.20M | $37.39M | $20.97M | $8.34M | $7.79M | $7.36M | $7.83M | $11.47M | $6.46M |
High Forecast | $104.69M | $106.22M | $105.93M | $105.34M | $105.00M | $103.04M | $100.57M | $91.36M | $88.15M | $89.96M | $84.99M | $79.16M | $76.67M | $71.56M | $65.82M | $56.43M | $59.49M | $37.39M | $20.97M | $8.34M | $7.79M | $7.36M | $7.83M | $11.47M | $6.46M |
Low Forecast | $87.32M | $88.59M | $88.35M | $87.86M | $87.57M | $85.94M | $83.88M | $83.10M | $83.02M | $75.03M | $70.89M | $66.03M | $58.22M | $59.68M | $54.90M | $47.06M | $49.62M | $37.39M | $20.97M | $8.34M | $7.79M | $7.36M | $7.83M | $11.47M | $6.46M |
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.59% | 0.82% | - | 0.90% | 0.92% | 1.10% | 1.53% | 2.69% | 0.85% | 0.81% | 0.73% | 0.72% | 1.15% |
Forecast
Immunocore EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-37.54M | $14.06M | - | $-13.56M | $-19.90M | $-6.94M | $-12.02M | $-14.77M | $-36.11M | $-29.23M | $-32.71M | $-30.05M | $-17.60M |
Avg Forecast | $-63.83M | $-64.76M | $-64.58M | $-64.22M | $-64.01M | $-62.82M | $-61.31M | $-59.78M | $-58.73M | $-54.85M | $-51.82M | $-48.26M | $-46.26M | $-43.63M | $-40.13M | $-34.40M | $-36.27M | $-25.48M | $-14.29M | $-15.89M | $-5.31M | $-5.02M | $-5.34M | $-19.39M | $-4.40M |
High Forecast | $-60.67M | $-61.55M | $-61.38M | $-61.05M | $-60.84M | $-59.71M | $-58.28M | $-57.74M | $-57.68M | $-52.13M | $-49.25M | $-45.87M | $-40.45M | $-41.47M | $-38.14M | $-32.70M | $-34.47M | $-25.48M | $-14.29M | $-12.71M | $-5.31M | $-5.02M | $-5.34M | $-15.51M | $-4.40M |
Low Forecast | $-72.74M | $-73.80M | $-73.60M | $-73.19M | $-72.95M | $-71.59M | $-69.87M | $-63.47M | $-61.24M | $-62.50M | $-59.05M | $-55.00M | $-53.27M | $-49.72M | $-45.73M | $-39.20M | $-41.33M | $-25.48M | $-14.29M | $-19.06M | $-5.31M | $-5.02M | $-5.34M | $-23.26M | $-4.40M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.81% | -0.32% | - | 0.39% | 0.55% | 0.27% | 0.84% | 0.93% | 6.80% | 5.83% | 6.13% | 1.55% | 4.00% |
Forecast
Immunocore Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-26.42M | $1.90M | - | $-16.70M | $-25.20M | $6.23M | $-6.12M | $-16.13M | $-39.39M | $-30.13M | $-32.96M | $-29.04M | $-18.88M |
Avg Forecast | $-8.32M | $-6.66M | $-5.41M | $-3.75M | $-15.76M | $-12.32M | $-10.39M | $-10.62M | $-10.11M | $-13.54M | $-19.86M | $-15.48M | $-10.35M | $-15.26M | $-16.24M | $-14.86M | $1.14M | $-12.59M | $-30.17M | $-17.35M | $-39.90M | $-41.60M | $-34.97M | $-18.73M | $-39.00M |
High Forecast | $-7.79M | $-6.23M | $-5.06M | $-3.51M | $-14.74M | $-11.53M | $-9.72M | $-3.54M | $-2.22M | $-12.67M | $-18.58M | $-14.48M | $-2.59M | $-14.28M | $-15.19M | $-13.90M | $1.35M | $-12.59M | $-30.17M | $-13.88M | $-39.90M | $-41.60M | $-34.97M | $-14.99M | $-39.00M |
Low Forecast | $-9.84M | $-7.87M | $-6.39M | $-4.43M | $-18.62M | $-14.56M | $-12.27M | $-18.58M | $-22.94M | $-16.00M | $-23.46M | $-18.29M | $-17.75M | $-18.03M | $-19.18M | $-17.55M | $1.07M | $-12.59M | $-30.17M | $-20.82M | $-39.90M | $-41.60M | $-34.97M | $-22.48M | $-39.00M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.55% | -0.12% | - | 1.12% | -22.09% | -0.49% | 0.20% | 0.93% | 0.99% | 0.72% | 0.94% | 1.55% | 0.48% |
Forecast
Immunocore SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $64.19M | $10.99M | - | $33.30M | $43.14M | $25.88M | $24.51M | $20.11M | $24.37M | $20.05M | $23.80M | $20.18M | $14.17M |
Avg Forecast | $143.40M | $145.49M | $145.09M | $144.29M | $143.82M | $141.14M | $137.75M | $134.30M | $131.95M | $123.22M | $116.42M | $108.43M | $103.94M | $98.02M | $90.16M | $77.29M | $81.49M | $58.37M | $32.73M | $13.02M | $12.15M | $11.49M | $12.23M | $17.90M | $10.08M |
High Forecast | $163.42M | $165.80M | $165.35M | $164.44M | $163.90M | $160.85M | $156.98M | $142.60M | $137.59M | $140.42M | $132.67M | $123.57M | $119.68M | $111.70M | $102.75M | $88.08M | $92.86M | $58.37M | $32.73M | $13.02M | $12.15M | $11.49M | $12.23M | $17.90M | $10.08M |
Low Forecast | $136.30M | $138.29M | $137.91M | $137.15M | $136.70M | $134.15M | $130.93M | $129.72M | $129.59M | $117.12M | $110.65M | $103.06M | $90.89M | $93.17M | $85.70M | $73.46M | $77.45M | $58.37M | $32.73M | $13.02M | $12.15M | $11.49M | $12.23M | $17.90M | $10.08M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 0.11% | - | 0.43% | 0.53% | 0.44% | 0.75% | 1.54% | 2.00% | 1.75% | 1.95% | 1.13% | 1.41% |
Forecast
Immunocore EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.00 | $0.04 | - | $-0.35 | $-0.54 | $0.13 | $-0.14 | $-0.37 | $-0.90 | $-0.69 | $-0.75 | $-0.76 | $-0.49 |
Avg Forecast | $-0.16 | $-0.13 | $-0.10 | $-0.07 | $-0.30 | $-0.23 | $-0.20 | $-0.20 | $-0.19 | $-0.26 | $-0.38 | $-0.29 | $-0.20 | $-0.29 | $-0.31 | $-0.28 | $0.02 | $-0.25 | $-0.60 | $-0.84 | $-0.80 | $-0.83 | $-0.70 | $-0.60 | $-0.78 |
High Forecast | $-0.15 | $-0.12 | $-0.10 | $-0.07 | $-0.28 | $-0.22 | $-0.18 | $-0.07 | $-0.04 | $-0.24 | $-0.35 | $-0.27 | $-0.05 | $-0.27 | $-0.29 | $-0.26 | $0.03 | $-0.25 | $-0.60 | $-0.84 | $-0.80 | $-0.83 | $-0.70 | $-0.60 | $-0.78 |
Low Forecast | $-0.19 | $-0.15 | $-0.12 | $-0.08 | $-0.35 | $-0.28 | $-0.23 | $-0.35 | $-0.43 | $-0.30 | $-0.44 | $-0.35 | $-0.34 | $-0.34 | $-0.36 | $-0.33 | $0.02 | $-0.25 | $-0.60 | $-0.84 | $-0.80 | $-0.83 | $-0.70 | $-0.60 | $-0.78 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | -0.14% | - | 1.24% | -24.99% | -0.52% | 0.23% | 0.44% | 1.13% | 0.83% | 1.07% | 1.27% | 0.63% |
Forecast
Immunocore Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
VTYX | Ventyx Biosciences | - | - | 1857.23% | Buy |
LRMR | Larimar Therapeutics | - | - | 231.65% | Buy |
LYRA | Lyra Therapeutics | - | - | 177.78% | Hold |
ERAS | Erasca | - | - | 150.00% | Buy |
KALV | KalVista Pharmaceuticals | - | - | 142.98% | Buy |
IMCR | Immunocore | - | - | 120.27% | Buy |
VRDN | Viridian Therapeutics | - | - | 93.27% | Buy |
DSGN | Design Therapeutics | - | - | 73.61% | Buy |
PCVX | Vaxcyte | - | - | 40.29% | Buy |
MIRM | Mirum Pharmaceuticals | - | - | 31.67% | Buy |
DICE | DICE Therapeutics | - | - | 26.18% | Buy |
NUVL | Nuvalent | - | - | 20.32% | Buy |
ACLX | Arcellx | - | - | -4.84% | Buy |
GRCL | Gracell Bio | - | - | -41.46% | Buy |